H1

H1 is the connecting force for global HCP, clinical, scientific and research information.

[H1 @H1com_]

With provider directory accuracy now a regulatory requirement, health plans can no longer rely on periodic audits to keep pace.

See why provider data has become critical infrastructure and discover practical strategies to improve accuracy at scale: https://t.co/8LaRXTdHKX

[H1 @H1com_]

Bad provider data already costs health plans billions each year. New accuracy requirements from the #REALHealthProvidersAct will only amplify the impact.

Download the guide to see how to prepare: https://t.co/XIAyMpWf9u

[H1 @H1com_]

Meeting the new #REALHealthProvidersAct requirements will depend on more than incremental changes. Health plans need to build defensible accuracy now. 

Download our guide to learn the practical steps your organization can take to prepare. https://t.co/wPEMEGt5Nd

[H1 @H1com_]

In an article for @MHExecutive, our CEO Ariel Katz explores how Most Favored Nation drug pricing is influencing clinical trial design, R&D investment, and global research strategies: https://t.co/R0Ocrh0twO

[H1 @H1com_]

While the REAL Health Providers Act raises the bar for provider directory accuracy, it also offers health plans an opportunity to build a stronger foundation.

In this @ChiefHealthExec article, discover the steps health plans can take today to prepare: https://t.co/w16EsJfYL2

[H1 @H1com_]

Ghost networks are becoming an increasing regulatory and legal risk.

Our latest blog explores why ghost networks are back in the spotlight and how AI is helping health plans move from to continuous provider data accuracy.

Read it here: https://t.co/tI5T9pKjRj

[H1 @H1com_]

2028 may seem far away, but for health plans, it isn't.

New regulatory requirements are raising the stakes for provider directory accuracy. The plans that start building now will be best positioned when compliance requirements intensify.

Learn more: https://t.co/tBbtuVvMc4

[H1 @H1com_]

The air is abuzz with talk about #AI in clinical trials, but according to a panel of healthcare leaders, AI alone isn't the answer. Read the blog post to learn why they believe that data, not interfaces, will be the true competitive advantage: https://t.co/OwHb2IFkiJ

[H1 @H1com_]

Ghost networks are becoming an increasing regulatory and legal risk.

Our latest blog explores why ghost networks are back in the spotlight and how AI is helping health plans move from to continuous provider data accuracy.

Read it here: https://t.co/L6lmGTu8Ia

[H1 @H1com_]

It's been great meeting with so many of you at #CTOEastCoast this week. We're still available for live 10-minute demos of our AI-driven trial insights today. Stop by to see how we can help identify best-fit sites and investigators for your trial protocols. Come see us in Booth 9!

[H1 @H1com_]

We're at #CTOEastCoast today!

The pressure is on for oncology teams to identify the right sites, investigators & patients for clinical trials. Let us show you how data-driven insights can accelerate startup and enrollment planning.

Stop by Booth 9 for a live 10-minute demo!

[H1 @H1com_]

At #CTOEastCoast, we're giving live demos to show how H1 can help oncology teams find the right sites, investigators, and patients before study startup begins.

Visit us at Booth 9 to get a live ⏱️ 10-minute demo June 30–July 1.

Reserve your spot now! https://t.co/OSt3zI7uBf

[H1 @H1com_]

Next week we’ll be at #CTOEastCoast! Give us 10 minutes to show you how H1 can fit your workflow and deliver the right data to power your next trial.

📅 June 30 – July 1, 2026
📍 Visit us at Booth 9 for a live 10-minute demo. 

Reserve your spot today: https://t.co/RdxYhUhhpe

[H1 @H1com_]

2028 may seem far away, but for health plans, it isn't.

New regulatory requirements are raising the stakes for provider directory accuracy. The plans that start building now will be best positioned when compliance requirements intensify.

Learn more: https://t.co/pHs66Bv4w2

[H1 @H1com_]

Using traditional methods of site selection, it can take hours of searching, filtering, and manual outreach. H1’s Site Network Suite brings site selection and feasibility into a single, AI-powered workflow. Discover modern clinical trial planning: https://t.co/A4rQgO6SWc

[H1 @H1com_]

In this article on @PharmaPhorum, H1 CEO Ariel Katz shares how sponsors are significantly shortening the feasibility process with AI-driven, evidence-based technology while simultaneously providing structured, site-validated data. See how: https://t.co/6KmM2utarq

[H1 @H1com_]

Regulators are tightening requirements around provider data accuracy, access, and update cycles. In this playbook, learn how health plans are modernizing provider data infrastructure to maintain regulatory readiness. https://t.co/w4jEHk7GR3

[H1 @H1com_]

The air is abuzz with talk about #AI in clinical trials, but according to a panel of healthcare leaders, AI alone isn't the answer. Read the blog post to learn why they believe that data, not interfaces, will be the true competitive advantage: https://t.co/nASuLnifeH

[H1 @H1com_]

Using traditional methods of site selection, it can take hours of searching, filtering, and manual outreach. H1’s Site Network Suite brings site selection and feasibility into a single, AI-powered workflow. Discover modern clinical trial planning: https://t.co/1bStv0KtUp

[H1 @H1com_]

Thanks to everyone who was able to join our #AHIP26 session this morning! Chris Gardella shared how AI is accelerating and refining provider data validation.

If you’d like to learn more and see our AI-driven provider data solutions live, come see us in Booth 1928.